Integra Lifesciences Holdings (IART) Revenue Growth (3y) (2012 - 2026)

Integra Lifesciences Holdings (IART) Revenue Growth (3y) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (3y) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 4.63%
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 8.01%
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 5.28%
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 15.36%
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 10.52%
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 2.92%
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.73%
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 17.14%
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 7.43%
10 Integra Lifesciences Holdings 1.37 Bn 1.10 Bn 216.98 Mn 0.96%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.96%
Dec 31, 2025 3.00%
Sep 30, 2025 1.44%
Jun 30, 2025 1.47%
Mar 31, 2025 0.53%
Dec 31, 2024 2.96%
Sep 30, 2024 -0.52%
Jun 30, 2024 2.35%
Mar 31, 2024 0.81%
Dec 31, 2023 0.71%
Sep 30, 2023 1.09%
Jun 30, 2023 13.81%
Mar 31, 2023 2.44%
Dec 31, 2022 0.24%
Sep 30, 2022 0.53%
Jun 30, 2022 1.22%
Mar 31, 2022 1.55%
Dec 31, 2021 1.90%
Sep 30, 2021 1.88%
Jun 30, 2021 2.12%